EMBECTA CORP. Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent
EMBECTA CORP. (EMBC) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent · last filed 2026-08-07
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2026-06-30 was $0.00.
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2026-03-31 was $0.00.
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2025-12-31 was -$300.00K.
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2025-09-30 was -$200.00K.
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2025 was -$200.00K, a 111.76% decline from fiscal 2024.
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2024 was $1.70M, a 6.25% increase from fiscal 2023.
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2023 was $1.60M.
- EMBECTA CORP. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2022 was $0.00.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | -$300.00K 10-Q · filed 2026-08-07 | -$500.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | -$300.00K 10-Q · filed 2026-05-05 | -$500.00K derived: sum of 3 quarters · filed 2026-05-05 | -$500.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$300.00K 10-Q · filed 2026-02-05 | -$500.00K derived: sum of 2 quarters · filed 2026-02-05 | -$500.00K derived: sum of 3 quarters · filed 2026-08-07 | -$500.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$200.00K derived: sum of 2 quarters · filed 2026-08-07 | -$200.00K derived: sum of 3 quarters · filed 2026-08-07 | -$200.00K 10-K · filed 2025-11-25 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 10-Q · filed 2026-05-05 | ||
| 2024-12-31 | $0.00 10-Q · filed 2026-02-05 | |||
| 2024-09-30 | $1.70M 10-K · filed 2025-11-25 | |||
| 2023-09-30 | $1.60M 10-K · filed 2025-11-25 | |||
| 2022-09-30 | $0.00 10-K · filed 2024-12-11 | |||
| 2021-09-30 | $0.00 10-K · filed 2023-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |